A decision by a federal judge in Florida to put a CBD lawsuit on hold pending federal clarity on the extract signals the judiciary isn’t yet ready to start hearing class action claims against the industry.
In the Florida case, the judge decided that the federal health agency’s current rules “provide little guidance with respect to whether CBD ingestibles, in all their variations are food supplements, nutrients or additives and what labeling standards are applicable.”
U.S. District Judge Ursula Ungaro ruled Jan. 3 that a CBD manufacturer shouldn’t face certain liability claims until the U.S. Food and Drug Administration (FDA) finishes work reviewing CBD policy. That FDA review was promised last year, but has yet to appear.